|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,985.00 GBX | +1.02% |
|
+1.53% | -4.57% |
| 07-09 | PureTech Health directors buy GBP176,000 in shares | AN |
| 05-20 | S&U says first quarter profitability ahead of last year and budget | AN |
Company Valuation: S&U plc
Data adjusted to current consolidation scope
| Fiscal Period: February | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 318.2 | 252.7 | 244.2 | 190.2 | 289.2 | 238.8 | - | - |
| Change | - | -20.57% | -3.37% | -22.14% | 52.08% | -17.44% | - | - |
| Enterprise Value (EV) 1 | 432.6 | 446.1 | 469 | 190.2 | 289.2 | 242.1 | 232.6 | -311.2 |
| Change | - | 3.12% | 5.13% | -59.46% | 52.08% | -16.3% | -3.92% | -233.83% |
| P/E | 8.38x | 7.5x | 9.61x | 10.6x | 12.2x | 9.02x | 7.84x | 6.55x |
| PBR | 1.54x | 1.12x | 1.04x | 0.8x | 1.16x | 0.9x | 0.85x | 0.79x |
| PEG | - | -0.7x | -0.4x | -0.4x | 0.4x | 0.8x | 0.5x | 0.3x |
| Capitalization / Revenue | 3.62x | 2.46x | 2.12x | 1.64x | 2.69x | 1.96x | 1.66x | 1.4x |
| EV / Revenue | 4.92x | 4.34x | 4.06x | 1.64x | 2.69x | 1.98x | 1.61x | -1.82x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | 8.52x | 9.12x | 9.64x | 4.24x | 6.26x | 4.6x | 3.59x | -3.84x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 1.26 | 1.33 | 1.2 | 1 | 1.15 | 1.2 | 1.287 | 1.399 |
| Rate of return | 4.81% | 6.39% | 5.97% | 6.39% | 4.83% | 6.11% | 6.55% | 7.12% |
| EPS 2 | 3.127 | 2.775 | 2.092 | 1.474 | 1.952 | 2.177 | 2.505 | 3.002 |
| Distribution rate | 40.3% | 47.9% | 57.4% | 67.8% | 58.9% | 55.1% | 51.4% | 46.6% |
| Net sales 1 | 87.89 | 102.7 | 115.4 | 115.6 | 107.4 | 122.1 | 144.1 | 171 |
| EBITDA | 51.32 | 49.43 | 49.16 | - | - | - | - | - |
| EBIT 1 | 50.79 | 48.9 | 48.65 | 44.83 | 46.16 | 52.6 | 64.73 | 81 |
| Net income 1 | 37.98 | 33.72 | 25.44 | 17.91 | 23.71 | 26.42 | 30.55 | 37 |
| Net Debt 1 | 114.4 | 193.4 | 224.8 | - | - | 3.3 | -6.2 | -550 |
| Reference price 2 | 26.20 | 20.80 | 20.10 | 15.65 | 23.80 | 19.65 | 19.65 | 19.65 |
| Nbr of stocks (in thousands) | 12,145 | 12,151 | 12,151 | 12,151 | 12,151 | 12,151 | - | - |
| Announcement Date | 3/29/22 | 3/28/23 | 4/9/24 | 4/15/25 | 4/21/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 9.02x | 1.98x | - | 6.11% | 319M | ||
| 26.42x | 17.03x | - | 0.65% | 68.32B | ||
| 26.45x | 4.46x | 15.1x | -.--% | 38.03B | ||
| 25.28x | 5.15x | 25.56x | 0.08% | 31.09B | ||
| 18.36x | 12.44x | 23.68x | 1.12% | 25.82B | ||
| 7.74x | 1.83x | 3.45x | 1.76% | 23.69B | ||
| 28.59x | 4.22x | 12.41x | -.--% | 21.9B | ||
| 22.47x | 18.7x | 45.45x | 0.16% | 15.3B | ||
| 28.91x | - | - | - | 15.18B | ||
| Average | 21.47x | 8.23x | 20.94x | 1.24% | 26.63B | |
| Weighted average by Cap. | 23.64x | 9.97x | 19.44x | 0.54% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SUS Stock
- Valuation S&U plc
Select your edition
All financial news and data tailored to specific country editions
















